Unna Danner

Dr. Unna Danner

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
ADAlexandra Dingemans
Alexandra Dingemans
UDUnna Danner
Unna Danner
MPMelissa Parks
Melissa Parks
The purpose of the present review is to provide a summary of the research findings on emotion regulation in Binge Eating Disorder (BED). Negative emotions and maladaptive emotion regulation strategies play a role in the onset and maintenance of binge eating in BED. Anger and sadness, along with negative emotions related to interpersonal experiences (i.e., disappointment, being hurt or loneliness), seem to be particularly relevant. Individuals with BED have a tendency to suppress and ruminate on their unwanted emotions, which leads to increased psychopathological thoughts and symptoms. Compared to healthy controls, they use adaptive strategies, such as reappraisal, less frequently. Evidence concerning the causal relation between negative affect and binge eating is inconclusive and still very limited. While experimental studies in a laboratory setting lack ecological validity, ecological momentary assessment studies offer more promise at unraveling the causal relationship between emotions and binge eating. Increases in negative affect are found to be antecedents of binge eating in BED. However, there seems to be less support for the possibility that binge eating serves as a means to alleviate negative affect. Finally, BED seems to be related to other forms of maladaptive emotion regulation strategies, such as substance abuse and self-harm.

13 February 2012 in International Journal of Eating Disorders
Verified
Journal Article
Closed access
PDF file
UDUnna Danner
Unna Danner
NSNicole Sanders
Nicole Sanders
PSPaul A.M. Smeets
Paul A.M. Smeets
FMFloor van Meer
Floor van Meer
RARoger A.H. Adan
Roger A.H. Adan
AEAnnemarie A. van Elburg
Annemarie A. van Elburg

9 February 2011 in European Eating Disorders Review
Verified
Journal Article
Closed access
PDF file
UDUnna Danner
Unna Danner
COCarolijn Ouwehand
Carolijn Ouwehand
NHNoor L. van Haastert
Noor L. van Haastert
HHHellen Hornsveld
Hellen Hornsveld
DRDenise T. D. de Ridder
Denise T. D. de Ridder

1 March 2014 in Psychiatry Research
Verified
Journal Article
Closed access
UDUnna Danner
Unna Danner
LSLot Sternheim
Lot Sternheim
CECatharine Evers
Catharine Evers

15 May 2012 in European Eating Disorders Review
Verified
Journal Article
Closed access
PDF file
UDUnna Danner
Unna Danner
CECatharine Evers
Catharine Evers
FSF. Marijn Stok
F. Marijn Stok
AEAnnemarie A. van Elburg
Annemarie A. van Elburg
DRDenise T. D. de Ridder
Denise T. D. de Ridder

8 September 2016 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
TBTamara Berends
Tamara Berends
BMBerno Van Meijel
Berno Van Meijel
WNWillem Nugteren
Willem Nugteren
MDMathijs Deen
Mathijs Deen
UDUnna Danner
Unna Danner
AEAnnemarie A. van Elburg
Annemarie A. van Elburg
Relapse is common among recovered anorexia nervosa (AN) patients. Studies on relapse prevention with an average follow-up period of 18 months found relapse rates between 35 and 41 %. In leading guidelines there is general consensus that relapse prevention in patients treated for AN is a matter of essence. However, lack of methodological support hinders the practical implementation of relapse prevention strategies in clinical practice. For this reason we developed the Guideline Relapse Prevention Anorexia Nervosa. In this study we examine the rate, timing and predictors of relapse when using this guideline. Cohort study with 83 AN patients who were enrolled in a relapse prevention program for anorexia nervosa with 18 months follow-up. Data were analyzed using Kaplan-Meijer survival analyses and Cox regression. Eleven percent of the participants experienced a full relapse, 19 % a partial relapse, 70 % did not relapse. Survival analyses indicated that in the first four months of the program no full relapses occurred. The highest risk of full relapse was between months 4 and 16. None of the variables remained a significant predictor of relapse in the multivariate Cox regression analysis. The guideline offers structured procedures for relapse prevention. In this study the relapse rates were relatively low compared to relapse rates in previous studies. We recommend that all patients with AN set up a personalized relapse prevention plan at the end of their treatment and be monitored at least 18 months after discharge. It may significantly contribute to the reduction of relapse rates.